Literature DB >> 2731180

Population-based case-control study of ovarian cancer in Shanghai.

X O Shu1, L A Brinton, Y T Gao, J M Yuan.   

Abstract

A case-control study of 229 ovarian cancer cases (including 172 epithelial tumors) and an equal number of population-based controls was conducted during 1984 to 1986 in Shanghai, China, a low-risk area for ovarian cancer. Similar to studies in high-risk areas, the risk of epithelial tumors was high for nulliparous women (odds ratio, 1.6; 95% confidence interval, 0.8 to 3.2) and decreased with increasing number of livebirths (P less than 0.01). Early menarche and late menopause were associated with increased risk, with the trend in risk for age at menarche being statistically significant. In contrast to other studies, oral contraceptive use was not associated with reduced risk, although there was some reduction in risk for those with a prior tubosterilization or intrauterine device use. Risk was also elevated among those reporting a prior ovarian cyst, medroxyprogesterone use, a first degree family history of cancer, and occupational exposure to paint. Risk factors for the nonepithelial tumors were similar to the other cancers, although the power to detect differences was limited.

Entities:  

Keywords:  Asia; Biology; Cancer; Case Studies; China; Contraception; Contraceptive Methods; Contraceptive Usage; Control Groups; Demographic Factors; Developing Countries; Diseases; Eastern Asia; Economic Factors; Family Planning; Female Sterilization; Fertility; Fertility Measurements; Human Resources; Incidence; Iud; Measurement; Menarche; Menstruation; Neoplasms; Occupations; Oral Contraceptives; Ovarian Cancer--etiology; Ovulation; Parity; Population; Population Dynamics; Reproduction; Research Methodology; Risk Factors; Socioeconomic Factors; Socioeconomic Status; Sterilization, Sexual; Studies

Mesh:

Year:  1989        PMID: 2731180

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  Hormonal risk factors for ovarian cancer in the Albanian case-control study.

Authors:  Edlira Pajenga; Tefta Rexha; Silva Çeliku; Gazmend Bejtja; Mimoza Pisha
Journal:  Bosn J Basic Med Sci       Date:  2013-05       Impact factor: 3.363

2.  Harvard report on cancer prevention. Causes of human cancer. Reproductive factors.

Authors: 
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

3.  Pelvic inflammatory disease and the risk of ovarian cancer: a meta-analysis.

Authors:  Zhiyi Zhou; Fangfang Zeng; Jianhui Yuan; Jinling Tang; Graham A Colditz; Shelley S Tworoger; Britton Trabert; Xuefen Su
Journal:  Cancer Causes Control       Date:  2017-03-24       Impact factor: 2.506

4.  Changing trends in the incidence of ovarian neoplasia and its relationship with the risk factors: a report of 311 cases from north-eastern anatolia region.

Authors:  Elif Demirci; Ferah Tuncel Daloglu; Muhammet Calik; Eren Altun; Sare Sipal; Bunyamin Borekci
Journal:  Eurasian J Med       Date:  2014-08-26

5.  Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006.

Authors:  Tsogzolmaa Dorjgochoo; Xiao-Ou Shu; Hong-Lan Li; Han-Zhu Qian; Gong Yang; Hui Cai; Yu-Tang Gao; Wei Zheng
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

6.  Reproductive factors and incidence of epithelial ovarian cancer: a Norwegian prospective study.

Authors:  G Albrektsen; I Heuch; G Kvåle
Journal:  Cancer Causes Control       Date:  1996-07       Impact factor: 2.506

7.  Incomplete pregnancies and risk of ovarian cancer (Washington, United States).

Authors:  M T Chen; L S Cook; J R Daling; N S Weiss
Journal:  Cancer Causes Control       Date:  1996-07       Impact factor: 2.506

Review 8.  Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies.

Authors:  Christina B Rasmussen; Susanne K Kjaer; Vanna Albieri; Elisa V Bandera; Jennifer A Doherty; Estrid Høgdall; Penelope M Webb; Susan J Jordan; Mary Anne Rossing; Kristine G Wicklund; Marc T Goodman; Francesmary Modugno; Kirsten B Moysich; Roberta B Ness; Robert P Edwards; Joellen M Schildkraut; Andrew Berchuck; Sara H Olson; Lambertus A Kiemeney; Leon F A G Massuger; Steven A Narod; Catherine M Phelan; Hoda Anton-Culver; Argyrios Ziogas; Anna H Wu; Celeste L Pearce; Harvey A Risch; Allan Jensen
Journal:  Am J Epidemiol       Date:  2016-12-09       Impact factor: 4.897

9.  Oral contraceptives and the risk of all cancers combined and site-specific cancers in Shanghai.

Authors:  Karin A Rosenblatt; Dao L Gao; Roberta M Ray; Zakia C Nelson; Karen J Wernli; Wenjin Li; David B Thomas
Journal:  Cancer Causes Control       Date:  2008-08-15       Impact factor: 2.506

Review 10.  The relationship between oral contraceptive use, cancer and vascular disease.

Authors:  C La Vecchia; S Franceschi; P Bruzzi; F Parazzini; P Boyle
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.